Showing results (31-40 of 96) with videos related to
Sort By:
Pageof 10
Journal of Pharmacological Sciences|June 3, 2019
Muscarinic receptor binding of fesoterodine, 5-hydroxymethyl tolterodine, and tolterodine in rat tissues after the oral, intravenous, or intravesical administrationShizuo Yamada, Shiori Kuraoka, Yoshihiko Ito, et al.Pharmacology & Therapeutics|May 1, 2018
Basic and clinical aspects of antimuscarinic agents used to treat overactive bladderShizuo Yamada, Yoshihiko Ito, Saori Nishijima, et al.Journal of Pharmacological Sciences|May 14, 2016
Characterization of muscarinic and P2X receptors in the urothelium and detrusor muscle of the rat bladderMasaki Ogoda, Yoshihiko Ito, Yusuke Fuchihata, et al.The Journal of Urology|September 25, 2012
Improvement by phytotherapeutic agent of detrusor overactivity, down-regulation of pharmacological receptors and urinary cytokines in rats with cyclophosphamide induced cystitisSweety Nasrin, Eiji Masuda, Haruna Kugaya, et al.Journal of Robotic Surgery|October 3, 2025
Team-based learning curve and cost efficiency in robot-assisted hysterectomy: a four-phase CUSUM study of 915 casesIkuko Sakamoto, Takahiro Nozaki, Yoshihiko Ito, et al.Biological & Pharmaceutical Bulletin|April 2, 2009
Pharmacologically relevant receptor binding characteristics and 5alpha-reductase inhibitory activity of free Fatty acids contained in saw palmetto extractMasayuki Abe, Yoshihiko Ito, Luvsandorj Oyunzul, et al.Life Sciences|July 6, 2010
Noninvasive evaluation of brain muscarinic receptor occupancy of oxybutynin, darifenacin and imidafenacin in rats by positron emission tomographyAkira Yoshida, Shuji Maruyama, Dai Fukumoto, et al.Journal of Pharmacological Sciences|January 1, 2020
Direct in vitro and in vivo demonstration of muscarinic receptor binding by the novel radioligand, [3H]5-hydroxymethyltolterodine, in the bladder and other tissues of ratsShizuo Yamada, Shiori Kuraoka, Yoshihiko Ito, et al.Journal of Pharmacological Sciences|February 6, 2010
The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: bladder selectivity based on in vivo drug-receptor binding characteristics of antimuscarinic agents for treatment of overactive bladderAkira Yoshida, Tomomi Fujino, Shuji Maruyama, et al.Organic Letters|June 18, 2004
Highly enantioselective synthesis of chiral 3-substituted indolines by catalytic asymmetric hydrogenation of indolesRyoichi Kuwano, Kohei Kaneda, Takashi Ito, et al.Pageof 10